| Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. | |
| | |
MedLine Citation:
|
PMID: 22060105 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Minicucci L, Haupt M, Casciaro R, De Alessandri A, Bagnasco F, Lucidi V, Notarnicola S, Lorini R, Bertasi S, Raia V, Cialdella P, Haupt R. Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial. Background: Early stages of glucose metabolism impairment are a period at risk in the long-term prognosis of cystic fibrosis (CF). Slow-release synthetic insulin glargine can be a therapeutic tool in this metabolic condition. Methods: In this phase 3 multicenter, controlled, two-arm, randomized clinical study, glargine was administered up to a dosage of 0.15 U/kg/die for a period of 18 months. Primary endpoint was the improvement of nutritional status [body mass index (BMI) Z score], while glucose tolerance [hemoglobin A1c (HbA1C) and respiratory function (FEV1 predicted] improvement were the secondary endpoints. Results: Thirty-four subjects (18 in the glargine arm and 16 in the control arm) were evaluated. Adherence to insulin treatment was excellent. No significant adverse events were reported. There were no significant differences in BMI, HbA1C and FEV1 values between the two groups nor within groups, except for HbA1C improvement in the glargine arm at month +18 (p = 0.04). Conclusions: Glargine treatment was well accepted and tolerated. No real efficacy in improving clinical and glycometabolic conditions was demonstrated. Further studies are necessary to test glargine at higher dosage and for a longer follow-up period. |
| | |
Authors:
|
Laura Minicucci; Maria Haupt; Rosaria Casciaro; Alessandra De Alessandri; Francesca Bagnasco; Vincenzina Lucidi; Sara Notarnicola; Renata Lorini; Serenella Bertasi; Valeria Raia; Pietro Cialdella; Riccardo Haupt |
Related Documents
:
|
2588665 - Risk factors of ischemic brain stroke in korean diabetic patients--a retrospective study. 2382265 - Acid cholesteryl ester hydrolase activity of mononuclear leukocyte in type 2 (non-insul... 21300335 - Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stor... 22120775 - Pancreatic iron and glucose dysregulation in thalassemia major. 15920045 - Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial ... 17978595 - Angiotensin-converting enzyme inhibitors in the treatment of hypertension: an update. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-11-8 |
Journal Detail:
|
Title: Pediatric diabetes Volume: - ISSN: 1399-5448 ISO Abbreviation: - Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-8 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100939345 Medline TA: Pediatr Diabetes Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2011 John Wiley & Sons A/S. |
Affiliation:
|
Pediatric Department, CF Center, G. Gaslini Children Hospital, 16147 Genova, Italy Epidemiology and Biostatistics Section, Scientific Directorate, G. Gaslini Children Hospital, 16147 Genova, Italy Department of Pediatric Medicine, Cystic Fibrosis Unit, Bambino Gesù Children's Hospital, 00100, Roma, Italy CF Center, La Sapienza, 00100, Roma, Italy CF Center, Federico II University, 80100 Napoli, Italy Pediatric Department, CF Center, 70100 Cerignola (FG), Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Detection of Farnesyltransferase Interface Hot Spots through Computational Alanine Scanning Mutagene...
Next Document: A PORR domain protein required for rpl2 and ccmF(C) intron splicing and for the biogenesis of c-typ...